ICAD / iCAD: Another Great Candidate For My 'Bio Boom' Speculative Portfolio

NASHUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can't hide by more_horizontal

iCAD, Inc. (NASDAQ:ICAD ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Jessica Burns – Head-Global Communication more_horizontal

iCAD, Inc. (NASDAQ:ICAD ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Linnell Faber - Executive Assistant to CEO Dan more_horizontal

Icad (ICAD) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.14 p more_horizontal

It's certainly not easy to find millionaire-maker stocks if you only have $50,000 or less to invest. In order to turn that amount of money into $1 mil more_horizontal

iCAD, Inc. (NASDAQ:ICAD ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Dana Brown - President, Chief Executive Offi more_horizontal

Icad (ICAD) delivered earnings and revenue surprises of -9.09% and 0.63%, respectively, for the quarter ended December 2022. Do the numbers hold clues more_horizontal

iCAD, Inc. (NASDAQ:ICAD ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Linnell Faber - Executive Assistant to Ch more_horizontal